Grand Rapids, MI – July 24, 2024 – Shoulder Innovations, a cultivate(MD) portfolio company and leader in shoulder replacement technology, today announced the United States Patent and Trademark Office (USPTO) has granted nine new patents over the past 18 months that significantly expand the Company’s intellectual property portfolio. The newly granted patents cover key areas within […]
cultivate(MD) is excited announce a significant milestone achieved by one of our portfolio companies, SentiAR. The Valley Hospital in Ridgewood, New Jersey, has become the first in the state and one of the pioneers in the United States to treat a patient using SentiAR’s FDA-cleared holographic cardiac ablation visualization platform, CommandEP. This groundbreaking procedure marks the first instance
New Jersey’s First Holographic Cardiac Ablation Guided by SentiAR’s CommandEP Read More »
Grand Rapids, Mich., June 13, 2024 — Sterile Processing Express (SPDx) announced today that it has achieved a major milestone in its healthcare business development. SPDx has received an Advanced Sterile Processing Certification from DNV GL, a global independent certification, assurance, and risk management provider. “Our team has diligently built a quality management system to provide the
Grand Rapids, MI., February 27, 2024 – Virtual Incision, a cultivate(MD) portfolio company, has been granted marketing authorization of the MIRA™ Surgical System (MIRA) from the FDA. This marks a significant milestone as MIRA becomes the first miniaturized robotic-assisted surgery device in the world approved for adult colectomy procedures. The device was submitted via the FDA’s De Novo
The spaceMIRA, a groundbreaking surgical robot, embarks on a historic journey to the International Space Station, a collaborative effort involving the University of Nebraska and NASA. Virtual Incision Corporation, part of the cultivate(MD) portfolio and creator of the MIRA Surgical System (MIRA), has announced the departure of its spaceMIRA model to the International Space Station. The spaceMIRA’s
Virtual Incision’s Mini Surgical Robot Heads to Space Read More »
Physics-based STAGE™ quantitative output and ground truth data used with Canon AiCE (Advanced intelligent Clear-IQ Engine) deep learning reconstruction could significantly expand MRI access for neuroimaging BINGHAM FARMS, MI, and TUSTIN, CA, Jan. 16, 2024 – SpinTech MRI, creators of the STAGE™ (STrategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, and Canon Medical Systems
Grand Rapids, Mich., December 11, 2023 – cultivate(MD), a leader in medical device venture capital, is thrilled to announce that one of its portfolio companies, NSite Medical, has received FDA clearance for its groundbreaking AI-based scoliosis scanning application. This marks a significant milestone in advancing medical technology and offering new, innovative solutions for scoliosis management. NSite
cultivate(MD) Portfolio Company NSite Medical Announces FDA Clearance Read More »
Collaboration will assess operational and clinical impacts of STAGE through an analysis of neuroimaging efficiency, reporting workflows and clinical outcomes in actual cases. BINGHAM FARMS, MI, Nov. 27, 2023 – SpinTech MRI, creators of the STAGE™ (Strategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, today announced that Yale New Haven Hospital and
SpinTech MRI and Yale New Haven Hospital to Examine Impact of STAGE on MRI Read More »
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that they have made a significant investment into Nanochon, a Washington, D.C.—based regenerative cartilage innovator. Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring
cultivate(MD) Capital Funds LP Announce Investment into Nanochon Read More »
Grand Rapids, Mich., October 23, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that one of their portfolio companies, St. Louis, Missouri-based SentiAR, Inc., a pioneer in using Augmented Reality (AR) visualization technology for cardiac ablation procedures, has received their second
